Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (199)

« Back to Publications

Salvage Neck Dissection in Recurrent Head and Neck Squamous Cell Carcinoma After Primary Radiotherapy (RESCUE): An IReC Multicentre Consecutive Cohort Study.

Williamson A. et al, (2026), Head Neck

Salvage surgery for residual and recurrent head and neck squamous cell carcinoma (RESCUE): An IReC multicentre consecutive cohort study.

Williamson A. et al, (2026), Oral Oncol, 179

Refining the Multivariable Predictive‐Prognostic PREDICTR ‐ OPC Model for Survival in Surgical Escalation for Oropharyngeal Squamous Cell Carcinoma

Zhang LL. et al, (2026), The Laryngoscope

Surgery in the Management of Recurrent Head and Neck Cancer.

Williamson A. et al, (2026), Otolaryngol Clin North Am, 59, 181 - 197

Association between deep cervical lymph node dissection and dementia incidence in patients with head and neck cancer: a systematic review

Omar M. et al, (2026), European Journal of Plastic Surgery, 49

ctDNA to Predict Treatment Response in Head and Neck Squamous Cell Carcinoma: A Systematic Review.

Jones O. et al, (2026), Laryngoscope, 136, 50 - 62

Impact of the BDNF Val66Met Polymorphism on Recovery Following Peripheral Nerve Injury: A Systematic Review

Hirayama Y. et al, (2026)

Anatomy and physiology of the salivary glands

Winter S. and Ishii H., (2026), 2165 - 2173

Immune biomarkers for head and neck cancer.

Sobhani N. et al, (2025), Cancer Immunol Immunother, 75

Multidisciplinary evidence-based consensus statements on salvage surgery for recurrent head and neck cancer (International Centre for Recurrent Head and Neck Cancer).

Williamson A. et al, (2025), J Natl Cancer Inst, 117, 2202 - 2218

Getting recovery right after neck dissection for head and neck cancer (GRRAND): trial protocol for a multicentre, pragmatic randomised controlled trial with health economic evaluation and process evaluation.

Evans C. et al, (2025), BMJ Open, 15

Circulating tumour DNA to augment PET-CT in determining clinical outcome after head and neck cancer treatment.

Bola S. et al, (2025), Eur J Cancer, 227

Immunotherapy for locally advanced head and neck cancer.

Kyzas P. et al, (2025), Br J Oral Maxillofac Surg, 63, 475 - 476

The COVIDTrach prospective cohort study on outcomes in 1982 tracheostomised COVID-19 patients during the first and second UK pandemic waves.

Haywood M. et al, (2025), Sci Rep, 15

Clinical Factors Influencing the Compliance With National Head and Neck Cancer Targets in the United Kingdom: Results From a National Cohort Study.

Lim AE. et al, (2025), Clin Otolaryngol, 50, 739 - 750

Load More

1
2
3
4
5
6
7
...
»